REGN
Regeneron Pharmaceuticals, Inc.
Biotechnology company focused on developing and commercializing medicines for serious diseases.
CUSIP: 75886F107HealthcareUS4 holders
Recent Activity
2025Q4
3 buys1 sell
-162.6K shares(-69.1%)
-162.6K shares(-69.1%)
+71.8K shares(+2.5%)
+71.8K shares(+2.5%)
+33.7K shares(+180.7%)
+33.7K shares(+180.7%)
+26.3K shares(+103.1%)
+26.3K shares(+103.1%)
Loading more activity...